Andrew Huberman· PhD
Kratom binds preferentially to the mu-opioid receptor and somewhat to the kappa opioid receptor.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Kratom binds preferentially to the mu-opioid receptor and somewhat to the kappa opioid receptor.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So the the easy one to get was Mitrogon and and and if you look at the majority of the literature around and there's almost a thousand papers in PubMed now. [...] metroin the major alkaloid actually has affinity for opioid receptors but very weak affinity and doesn't do much from an analesia or painkilling perspective which you would think the major one that's what it's there for that's what's going on.